Dan Brague

Dan Brague joined the Board of Polarean as a Non-Executive Director in May 2022. Dan is a highly accomplished executive leader with a background focused on enterprise growth and value creation. He has spent 25+ years in the Healthcare sector with the last 22 years in diagnostic imaging. His most recent role was as CEO of Curium North America, a leading global manufacturer of radiopharmaceuticals. Dan has led teams in the development and launch of new products that have had a transformative impact on those businesses. He has experience with both public and private equity ownership. He played key roles in the divestiture of Mallinckrodt Pharmaceutical’s Radiopharmaceutical business, the creation of Curium and M&A to grow that business.

Dan has a Bachelor of Arts degree from the University of Wisconsin at LaCrosse.